News | June 09, 2026
Bayer brings Alka-Seltzer to India touting first antacid with probiotic support
The launch comes against the backdrop of a significant public health burden
The launch comes against the backdrop of a significant public health burden
Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa
Broadening access for children & patients with inhibitor-complicated hemophilia
The company will present 21 oral and poster presentations spanning investigational and approved therapies
The campaign places renewed focus on a disease that remains incurable despite major scientific advances
Researchers say the results point to a potential shift in how obesity is treated—as a central disease driving multiple conditions, rather than a collection of separate problems
Community healthcare initiatives reach a milestone year, with services spanning 90 districts, 22 states, and over 70 lakh cumulative beneficiaries since 2006
The graduating cohort comprised seven batches across five specialized programs
Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
